YS Stock Earnings: YS Biopharma Co Misses EPS, Misses Revenue for Q2 2024
Source: iQoncept / Shutterstock
YS Biopharma Co (NASDAQ:YS) just reported results for the second quarter of 2024.
- YS Biopharma Co reported earnings per share of -16 cents. This was below the analyst estimate for EPS of -8 cents.
- The company reported revenue of $13.64 million.
- This was 40.97% worse than the analyst estimate for revenue of $23.11 million.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/01/ys-stock-earnings-ys-biopharma-co-for-q2-of-2024/.
©2024 InvestorPlace Media, LLC